Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_assertion type Assertion NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_head.
- NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_assertion description "[Clinical usefulness of a panel of beta2 integrins in accurate prediction of acute promyelocytic leukemia and recommendation of inclusion to identify patients who require retinoic acid therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_provenance.
- NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_assertion evidence source_evidence_literature NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_provenance.
- NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_assertion SIO_000772 16764927 NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_provenance.
- NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_assertion wasDerivedFrom lhgdn-20090331 NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_provenance.
- NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_assertion wasGeneratedBy ECO_0000203 NP143080.RA6HFR1TdZhIZJHe0q7jaS8UUhodpvFuGp5-ULm1Se4c0130_provenance.